Persistent hypertransaminasemia in asymptomatic children: a stepwise approach

World J Gastroenterol. 2013 May 14;19(18):2740-51. doi: 10.3748/wjg.v19.i18.2740.

Abstract

We aimed to examine the major causes of isolated chronic hypertransaminasemia in asymptomatic children and develop a comprehensive diagnostic flow diagram. A MEDLINE search inclusive of publications throughout August 2012 was performed. We found only a small number of publications that had comprehensively investigated this topic. Consequently, it was difficult to construct a diagnostic flowchart similar to those already available for adults. In children, a "retesting panel" prescription, including gamma-glutamyl transpeptidase and creatine kinase in addition to aminotransferases, is considered a reasonable approach for proficiently confirming the persistence of the abnormality, ruling out cholestatic hepatopathies and myopathies, and guiding the subsequent diagnostic steps. If re-evaluation of physical and historical findings suggests specific etiologies, then these should be evaluated in the initial enzyme retesting panel. A simple multi-step diagnostic algorithm incorporating a large number of possible pediatric scenarios, in addition to the few common to adults, is available. Accurately classifying a child with asymptomatic persistent hypertransaminasemia may be a difficult task, but the results are critical for preventing the progression of an underlying, possibly occult, condition later in childhood or during transition. Given the high benefit/cost ratio of preventing hepatic deterioration, no effort should be spared in diagnosing and properly treating each case of persistent hypertransaminasemia in pediatric patients.

Keywords: Aminotransferase; Children; Hypertransaminasemia; Liver disease; Transaminase.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Age Factors
  • Alanine Transaminase / blood*
  • Algorithms
  • Aspartate Aminotransferases / blood*
  • Biomarkers / blood
  • Child
  • Child, Preschool
  • Chronic Disease
  • Clinical Enzyme Tests*
  • Clinical Protocols
  • Decision Support Techniques
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Liver Diseases / blood
  • Liver Diseases / diagnosis*
  • Liver Diseases / etiology
  • Liver Diseases / therapy
  • Male
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors
  • Time Factors
  • Up-Regulation

Substances

  • Biomarkers
  • Aspartate Aminotransferases
  • Alanine Transaminase